Esophageal Squamous Intraepithelial Neoplasia
Showing 1 - 25 of 5,048
Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma
Recruiting
- Anal Cancer
- Anal Squamous Intraepithelial Neoplasia
-
London, United KingdomImperial College London- Chelsea and Westminster NHS Foundation
Apr 19, 2023
Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion Trial in Los Angeles, Oklahoma City
Recruiting
- Cervical Squamous Cell Carcinoma In Situ
- Vulvar High Grade Squamous Intraepithelial Lesion
- Cyclophosphamide
- +7 more
-
Los Angeles, California
- +1 more
Aug 19, 2022
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Cancer of Esophagus Trial in Offenbach (impedance)
Completed
- Cancer of Esophagus
- impedance
-
Offenbach, Hessen, GermanySana Clinic Offenbach
Jan 13, 2023
Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3 Trial in Netherlands
Recruiting
- Cervical High Grade Squamous Intraepithelial Lesion
- +3 more
- Imiquimod
- +3 more
-
Breda, Netherlands
- +12 more
Jun 21, 2022
Vulvar Intraepithelial Neoplasia, Vulvar High Grade Squamous Intraepithelial Lesion, Differentiated Vulvar Intraepithelial
Recruiting
- Vulvar Intraepithelial Neoplasia
- +2 more
- Metvixia Topical Cream
-
Vandœuvre-lès-Nancy, FranceInstitut de Cancerologie de Lorraine
Dec 3, 2021
AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia Trial in San Francisco,
Recruiting
- AIDS-Related Anal Carcinoma
- +4 more
- Biopsy
- +5 more
-
San Francisco, California
- +2 more
Jan 24, 2023
Primary Cervical Cancer Screening by Self-sampling HPV Test
Recruiting
- Human Papillomavirus Infection
- +16 more
-
Beijing, Beijing, China
- +5 more
Jan 12, 2023
Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial
Active, not recruiting
- Cervical Intraepithelial Neoplasia Grade 2/3
- +3 more
- Imiquimod
- Topical Fluorouracil
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jan 28, 2022
Esophageal Squamous Cell Neoplasia (ESCN) Trial in Beijing (Radiofrequency ablation)
Terminated
- Esophageal Squamous Cell Neoplasia (ESCN)
- Radiofrequency ablation
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Jul 29, 2020
Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial Neoplasia 2
Recruiting
- Cervical Intraepithelial Neoplasia
- +2 more
- Pembrolizumab
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Jan 20, 2022
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Anal Cancer Risk In Women
Recruiting
- Anal Cancer
- +4 more
- Dual Pathology
-
London, United Kingdom
- +1 more
Apr 19, 2023
Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)
Recruiting
- Papilloma Viral Infection
- +2 more
- Glizigen
- Placebo
-
Madrid, Spain
- +3 more
Jun 27, 2023
Cervical Intraepithelial Neoplasia Trial in Little Rock (PepCan, Candin®)
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- PepCan
- Candin®
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
May 17, 2022
Subjects Previously Enrolled in NCI Genitourinary Malignancies
Enrolling by invitation
- Cervical Intraepithelial Neoplasia
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Esophageal Tumors, Esophagus Stenosis Trial in Kaohsiung City (Oral prednisolone (30mg/day) for 28 days)
Recruiting
- Esophageal Neoplasms
- Esophagus Stenosis
- Oral prednisolone (30mg/day) for 28 days
-
Kaohsiung City, TaiwanEDA Hospital
Mar 14, 2023
Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting
- Human Papillomavirus Infection
- +17 more
-
Beijing, Beijing, China
- +2 more
Jan 21, 2022
High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle
Terminated
- High Grade Anal Canal Intraepithelial Neoplasia
- High Grade Vulvar Squamous Intraepithelial Lesion
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +1 more
Jan 24, 2023
Esophageal cAncer Screening Trial
Completed
- Esophageal Squamous Cell Carcinoma
- +2 more
- Sponge cytological test
-
Shanghai, Shanghai, ChinaChanghai Hospital
Sep 17, 2022
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Tucson, Arizona
- +52 more
Oct 13, 2022
Esophageal Tumors Trial (KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method))
Not yet recruiting
- Esophageal Neoplasms
- KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
- (no location specified)
Dec 25, 2022
Esophageal Squamous Cell Dysplasia Trial in Beijing (CryoBalloon Focal Ablation System)
Completed
- Esophageal Squamous Cell Dysplasia
- CryoBalloon Focal Ablation System
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Apr 18, 2022